The global medical tourism market is expanding rapidly as rising healthcare costs in developed nations push patients to seek affordable, high-quality treatment abroad. According to a newly published industry report, the market was valued at USD 39.84 billion in 2023 and is projected to grow from USD 44.19 billion in 2024 to USD 98.61 billion by 2031, registering a compound annual growth rate (CAGR) of 12.15% during the forecast period. Advancements in medical technology and the growing popularity of wellness tourism are identified as the primary drivers of this expansion.
Hospital-Travel Partnerships Simplify Cross-Border Care
Medical tourism involves traveling abroad for medical treatment, often to benefit from lower costs or reduced wait times, with procedures ranging from elective cosmetic surgery and dental work to complex cardiovascular and orthopedic interventions. Partnerships between hospitals and travel agencies have become increasingly important, offering comprehensive packages covering medical consultations, hospital bookings, travel arrangements, and accommodations, thereby simplifying what can otherwise be a complex cross-border healthcare journey.
According to Invest India, Apollo and Fortis have established International Patient Assistance Centers across several countries, partnering with local healthcare professionals, travel agencies, and wellness tourism agencies to streamline patient journeys. Popular medical tourism destinations, including Thailand, Mexico, India, and Turkey, offer world-class medical services at a fraction of the cost found in developed nations, often bundled with translators and concierge services.
Key Market Highlights
- The medical tourism industry was valued at USD 39.84 billion in 2023.
- The market is projected to grow at a CAGR of 12.15% from 2024 to 2031.
- Asia-Pacific accounted for a 38.56% share in 2023, valued at USD 15.36 billion.
- The cosmetic treatment segment captured the largest share at 37.56% in 2023.
- The online booking segment is expected to record a CAGR of 13.51% through the forecast period.
- The independent traveler segment garnered the highest revenue of USD 19.34 billion in 2023.
- North America is poised to grow at a robust CAGR of 11.87% in the forthcoming years.
Cosmetic Procedures Driving Segment Growth
Global demand for cosmetic procedures is rising due to increasing social acceptance, improved surgical techniques, and a growing inclination toward aesthetic enhancement. According to the International Society of Aesthetic Plastic Surgery, global aesthetic surgical procedures rose 5.5% in 2024, surpassing 15.8 million, alongside 19.1 million non-surgical treatments—with aesthetic procedures growing 40% over the past four years.
Countries such as Brazil, South Korea, and Turkey have become popular destinations for cosmetic procedures owing to their specialized expertise and affordable pricing, offering advanced medical facilities and customized services including translators, luxury accommodations, and post-surgical care packages tailored to international patients.
Quality and Safety Consistency Remains a Challenge
Ensuring consistent quality and safety across borders remains a significant challenge for the medical tourism industry, given varying regulations, accreditation systems, and medical standards between countries. The lack of consistent oversight for facilities catering to foreign patients raises concerns about safety and liability, especially for complex procedures. Addressing this requires international regulatory frameworks, universal accreditation systems, and greater transparency around hospital certifications and doctor qualifications to enhance patient trust globally.
Medical Technology Advancements Elevate Patient Confidence
Advancements in medical technology are revolutionizing the medical tourism market, with innovations such as robotic surgery, minimally invasive techniques, and advanced imaging improving the precision, safety, and effectiveness of procedures. These developments are reducing recovery times and minimizing risks, making international travel for complex treatments more attractive.
According to an April 2024 Medical Tourism Association survey, trust issues, poor patient experiences, and ineffective marketing strategies remain barriers to growth, with over 53% of respondents reporting a lack of patient leads—particularly in Asia Pacific (31.8%), North America (22.7%), and the Middle East (20.5%). Countries investing heavily in advanced medical technologies, such as Singapore, Germany, and South Korea, are emerging as leading destinations due to procedures not widely available elsewhere.
Segmentation Insights
By treatment, the cosmetic segment captured the largest share of 37.56% in 2023, fueled by growing societal acceptance of cosmetic surgeries and rising social media influence on physical appearance. By booking mode, the online segment is expected to record a CAGR of 13.51% through the forecast period, driven by increasing digitization and telemedicine adoption. By tourist type, independent travelers garnered the highest revenue of USD 19.34 billion in 2023, reflecting growing preference for personalized and flexible medical journeys.
Regional Analysis: Asia-Pacific Leads, North America Accelerates
Asia-Pacific accounted for a notable 38.56% share of the medical tourism market in 2023, valued at USD 15.36 billion, reinforced by affordable medical treatments, highly skilled healthcare professionals, and advanced medical facilities in Thailand, India, Malaysia, and Singapore. These nations offer complex surgeries and cosmetic treatments at competitive pricing, supported by well-developed tourism infrastructure that allows patients to combine treatment with leisure travel.
North America is poised to grow at a robust CAGR of 11.87% in the forthcoming years, driven by increasing outbound medical tourism as patients seek to avoid long wait times, high out-of-pocket expenses, and limited insurance coverage for certain procedures. Growing digital platform adoption and telemedicine are further facilitating this trend, enabling patients to consult international doctors and plan medical journeys more efficiently.
Competitive Landscape
The medical tourism market remains fragmented, with prominent players focusing on partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their portfolios and market share across regions. Strategic initiatives, including R&D investments and new facility establishments, continue to create opportunities for market growth.
Major companies operating in the market include Bumrungrad International Hospital, Apollo International, MedRetreat, Asian Heart Institute, Raffles Medical Group, Prince Court Medical Centre, Livonta Global, KASEMRAD INTERNATIONAL HOSPITAL VIENTIANE, Samitivej PCL, and KPJ Healthcare Berhad. In January 2024, Ferns N Petals unveiled MediJourney, its global medical tourism division offering specialist consultations, medical visa assistance, and tele-medicine services. In June 2023, Bumrungrad International Hospital in Phuket initiated a strategic expansion establishing a 150-bed facility with advanced diagnostic technologies.
Outlook
With Asia-Pacific expected to grow at a CAGR of 12.80% to reach USD 40.23 billion, and the independent traveler segment projected to hit USD 52.11 billion by 2031, the medical tourism market is set for sustained, technology-enabled expansion. As telemedicine, AI-driven diagnostics, and hospital-travel partnerships continue to mature, providers that prioritize transparency, accreditation, and personalized patient journeys will be best positioned to capture growing global demand.